Literature DB >> 7895748

Paraplegia at the Tikur Anbessa Teaching Hospital: a seven year retrospective study of 164 cases.

G Zenebe1, K Oli, R Tekle-Haimanot.   

Abstract

Admission analysis of adult non-traumatic paraplegia and paraparesis from 1981 to 1988 was carried out. Information was collected from charts of 223 consecutive admissions according to a pre-set protocol. Paraplegia or paraparesis was responsible for 164(13.4%) of all neurological admissions over the study period. The median age of the patients was 36 years with a male to female ratio of 1.7:1. Tuberculosis was the leading cause of paraplegia or paraparesis accounting for 47% of the cases. Tumours (20%), Landry-Guillain-Barre' syndrome (12.2%) and tropical spastic paraparesis (TSP) (9.8%) were important but less frequent causes in this series. Other causes like disc prolapse, transverse myelitis, spinal artery stroke and fluorosis were rarely encountered. Vertebral deformity (88.1%), vertebral tenderness (88.1%) and abnormal plain spinal X-ray (89%) were the most helpful findings in the diagnosis of tuberculous paraplegia. Nearly all cases of tuberculous paraplegia were treated medically alone. However, the outcome of treatment as judged by the treating physicians was good with a significant response recorded in 78%.

Entities:  

Mesh:

Year:  1995        PMID: 7895748

Source DB:  PubMed          Journal:  Ethiop Med J        ISSN: 0014-1755


  2 in total

1.  Transverse myelitis due to trypanosomiasis in a middle aged Tanzanian man.

Authors:  G S Kibiki; D K Murphy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

Review 2.  A Systematic Review of Non-Traumatic Spinal Cord Injuries in Sub-Saharan Africa and a Proposed Diagnostic Algorithm for Resource-Limited Settings.

Authors:  Abdu Kisekka Musubire; David B Meya; Paul R Bohjanen; Elly Tebasooke Katabira; Patrice Barasukana; David R Boulware; Ana-Claire Meyer
Journal:  Front Neurol       Date:  2017-12-08       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.